🇺🇸 FDA
Pipeline program

MBX 4291

MBX-4O3001

Phase 1 small_molecule active

Quick answer

MBX 4291 for Obesity is a Phase 1 program (small_molecule) at MBX Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
MBX Biosciences
Indication
Obesity
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials